Charleston HFpEF Virtual Conference: The Latest Knowledge on Heart Failure with preserved Ejection Fraction
Avatar

Obesity and Weight Management in HFpEF: How Effective and Safe Are Weight-Loss Drugs?

By Charleston HFpEF Virtual Conference: The Latest Knowledge on Heart Failure with preserved Ejection Fraction FEATURING Sheldon Litwin
June 15, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

01:52
Novo Nordisk – GLP-1 RA Therapy

T2D Treatment After Oral Agents: What Is the Next Step?

Feat. C. Wierum, L. Coco

Featured Video

09:22
Novo Nordisk – GLP-1 RA Therapy

GLP-1 RA as a First Injectable for T2D: What Is the Safety and Effic…

Feat. R. Pratley

Related Content

AUTOPLAY
Didactic Presentations

International Federation for the Surgery of Obesity and Metabolic Di…

Tue, Aug 23, 2022
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
34:25
Cedars Sinai

Endoscopic Management of Complications in Bariatric Surgery

Feat. K. H. Park
37:48
Scripps Health

Cardiodiabetology: Expanding Your Specialty

Feat. S. Harris
12:18
Mayo Clinic Proceedings

Mortality Risk by BMI, Exercise Ability & Capacity in Stress Tes…

Feat. A. Rozanski
10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez
06:12
Mayo Clinic Proceedings

Obesity Pharmacotherapy Trends in the United States

Feat. F. Stanford
28:32
Weill Cornell Medicine Courses and Meetings

Hypothalamic Obesity

Feat. B. Tchang
20:56
Stanford Medicine

COVID-19 & Diabetes Treatment: Can We Reduce the Risk of Poorer …

Feat. A. Peters
17:16
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Approaches to Treating Diabetes that Reduce CV Events: How Effective…

Feat. J. Shen
11:31
Domenica Rubino

Weight Loss Maintenance for Adults With Once-Weekly Semaglutide: Wha…

14:52
Richard Pratley

Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study

14:50
Robert Eckel

COVID-19 & Diabetes: How to Manage SGLT2, GLP-1 RAs, Metformin, …

25:54
13th Orange County Symposium for Cardiovascular Disease Prevention

SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Whic…

Feat. Y. Handelsman
27:50
Scripps Health: 2019 Updates in Diabetes Management

Management of Hyperglycemia: Impact on Complications in the CVOT Era

Feat. D. Einhorn
09:24
Cardiometabolic Health Congress (CMHC)

SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Have We Learned F…

Feat. R. Eckel
15:25
LivDerm

Looking at the Skin from Within: Nexis Between the Gut and Skin

Feat. T. LePine